MP06-15 VIRTUAL REALITY IMMERSION FOR REDUCING ANXIETY AND PAIN DURING TRANSPERINEAL PROSTATE BIOPSY: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP06-15 VIRTUAL REALITY IMMERSION FOR REDUCING ANXIETY AND PAIN DURING TRANSPERINEAL PROSTATE BIOPSY: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL Phillip Kim and Marc Dall'era Phillip KimPhillip Kim More articles by this author and Marc Dall'eraMarc Dall'era More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003217.15AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Approximately two million men undergo prostate biopsies annually in the United states for the detection of prostate cancer. Given the invasiveness of the procedure, a prostate biopsy by any approach can be a traumatic process for patients. Due to rising rates of antibiotic resistant bacteria and infections associated with transrectal prostate biopsy, the transperienal (TP) approach is becoming more common. As of today, no study has assessed whether VR simulation can help improve patients’ experiences during TP biopsy. We aimed to study the role of Virtual Reality (VR) immersion during trans-perineal (TP) prostate biopsies for reducing perceived anxiety and pain associated with the procedure. METHODS: We conducted an IRB-approved, prospective, randomized study of 60 men who presented for TP prostate biopsy. The men were randomized 1:1 to undergo the procedure with VR who were then immersed in a calming, nature scenery. The control group underwent the procedure without VR. The procedure was performed under local anesthetic with 1% lidocaine used to anesthetize the perineal skin and prostate per standard protocol. The primary outcome of our study was pain, anxiety and degree of nausea during the procedure assessed by a 10 cm Visual Analog Scale given pre- and post-procedure. Vital signs such as blood pressure, heart rate, and oxygen saturation were measured. For those who were in the VR group, patients were further asked if they would recommend VR for other patients. Mann Whitney-U test was utilized to assess the difference between the two groups. The statistical significant level was p<0.05. RESULTS: All 60 patients were able to complete the TP biopsy. The mean age (years) of the cohort was 70. The VR group’s mean age was 69.6 vs 70.5 in the control group, p=0.29. Both VR and the control group had similar pre-procedure anxiety level [VR 5.8 vs Control 5.2, p=0.18]. Peri-procedure anxiety level was lower in the VR group (4.1) compared to the Control group (6.9), p<0.01. The VR group also reported lower perceived pain levels compared to the control group [4.0 vs 5.6, respectively, p<0.01]. Among the 30 patients who were in the VR group, 27 patients recommended VR use for other patients. The remaining 3 had prostate biopsy in the past. No patients experienced any nausea or dizziness associated with the VR immersion during the biopsy. CONCLUSIONS: TP biopsy is feasible in the office-based setting under local anesthetic. VR immersion technology can be a useful tool in improving patients’ experience by reducing both pain and anxiety during the procedure. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e59 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Phillip Kim More articles by this author Marc Dall'era More articles by this author Expand All Advertisement PDF downloadLoading ...